QHP Capital

QHP Capital is a private equity firm with $4.5 billion in assets under management that invests in middle-market healthcare companies, including tech-enabled services, pharmaceuticals, and clinical research organizations. The firm partners with management teams to acquire and grow healthcare businesses through operational improvements and strategic repositioning, with a portfolio that includes companies such as Azurity Pharmaceuticals, Catalyst Clinical Research, Core-Rx, and Clinical Ink.